MARROSU, MARIA GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 413.395
NA - Nord America 19.252
AS - Asia 3.573
SA - Sud America 352
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 18
Totale 436.650
Nazione #
IT - Italia 408.320
US - Stati Uniti d'America 19.110
CN - Cina 1.913
UA - Ucraina 1.821
SG - Singapore 1.360
SE - Svezia 1.054
DE - Germania 605
GB - Regno Unito 562
FI - Finlandia 528
BR - Brasile 331
FR - Francia 208
CA - Canada 119
NL - Olanda 68
IN - India 56
RU - Federazione Russa 47
BE - Belgio 42
VN - Vietnam 41
HK - Hong Kong 39
KR - Corea 33
AT - Austria 21
EU - Europa 21
ES - Italia 19
CZ - Repubblica Ceca 18
IR - Iran 17
IL - Israele 16
AU - Australia 15
TR - Turchia 13
RO - Romania 10
ZA - Sudafrica 10
JP - Giappone 9
MX - Messico 9
AZ - Azerbaigian 8
BD - Bangladesh 8
EC - Ecuador 8
IE - Irlanda 8
MU - Mauritius 8
CH - Svizzera 7
MA - Marocco 7
PK - Pakistan 7
PL - Polonia 7
AL - Albania 6
CU - Cuba 6
DK - Danimarca 6
KG - Kirghizistan 6
UZ - Uzbekistan 6
PT - Portogallo 5
AR - Argentina 4
BG - Bulgaria 4
DZ - Algeria 4
JO - Giordania 4
LT - Lituania 4
NO - Norvegia 4
CO - Colombia 3
EE - Estonia 3
EG - Egitto 3
HR - Croazia 3
HU - Ungheria 3
IQ - Iraq 3
LU - Lussemburgo 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
ID - Indonesia 2
KH - Cambogia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
OM - Oman 2
PS - Palestinian Territory 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MC - Monaco 1
ML - Mali 1
NP - Nepal 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 436.649
Città #
Cagliari 401.224
Uta 5.904
Fairfield 2.579
Woodbridge 2.181
Chandler 1.562
Houston 1.433
Ashburn 1.404
Wilmington 1.146
Ann Arbor 1.055
Seattle 1.007
Boardman 926
Jacksonville 900
Cambridge 861
Nyköping 722
Singapore 555
Dearborn 400
Nanjing 352
Beijing 257
Helsinki 234
Boston 233
Santa Clara 210
Shanghai 205
New York 189
Milan 160
San Diego 133
Shenyang 126
Nanchang 105
Toronto 96
The Dalles 95
Munich 92
Hebei 91
Redwood City 90
Guangzhou 89
Jiaxing 86
Norwalk 83
Verona 82
Changsha 75
Los Angeles 68
London 64
Washington 60
Sassari 56
Tianjin 48
Mountain View 46
Jinan 43
Dong Ket 40
Zhengzhou 40
Ningbo 37
Hangzhou 36
Hong Kong 35
Atlanta 34
Auburn Hills 32
Brussels 32
Orange 30
Rome 29
Hefei 27
Kunming 27
Pune 26
Taizhou 26
Seoul 25
São Paulo 22
Council Bluffs 19
Falls Church 18
Düsseldorf 17
Nuremberg 17
Millbury 16
Phoenix 15
Frankfurt am Main 14
Wuhan 14
Amsterdam 13
Chicago 13
Edinburgh 13
Rio de Janeiro 13
Borås 12
Saint Petersburg 12
Vienna 12
Belo Horizonte 11
Brno 11
Indiana 11
Porto Alegre 11
Augusta 10
Domusnovas 10
Kilburn 10
Redmond 10
Fuzhou 9
Baku 8
Bologna 8
Brasília 8
Detroit 8
Lauterbourg 8
Leawood 8
Madrid 8
Newark 8
Stockholm 8
Dublin 7
Palermo 7
Portsmouth 7
San Mateo 7
Shenzhen 7
Turin 7
Ardabil 6
Totale 428.256
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.096
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.850
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.133
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.860
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.489
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.415
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.402
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.327
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.240
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.204
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.136
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.135
Overexpression of the cytokine BAFF and autoimmunity risk 3.983
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.944
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.939
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.845
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.826
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.785
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.774
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.744
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.743
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.731
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.642
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.615
Walking improvements with nabiximols in patients with multiple sclerosis 3.605
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.593
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.540
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.516
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.510
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.481
Dynamical insights into the differential characteristics of Mycobacterium avium subsp. paratuberculosis peptide binding to HLA-DRB1 proteins associated with multiple sclerosis 3.361
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.344
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.329
Impact of the media on future hope in multiple sclerosis 3.325
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.230
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.227
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.221
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.175
Oral agents in multiple sclerosis 3.159
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.151
Influence of treatments in multiple sclerosis disability: a cohort study 3.115
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.038
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.021
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. 2.987
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 2.987
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 2.955
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.921
Refining the connection between gait and cognition: training the body to improve the brain 2.910
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.900
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.900
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.859
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.811
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.787
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.758
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.664
Postural adaptation during a Nintendo Wii balance training 2.608
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.605
Perception of risk and shared decision making process in multiple sclerosis 2.589
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.579
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.547
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.499
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.496
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.487
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.450
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients 2.446
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.381
Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia 2.366
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.353
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.279
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.265
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.259
The cohort of the multiple sclerosis center of Cagliari 2.257
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement 2.256
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.230
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.230
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.213
Induction and escalation therapies in multiple sclerosis 2.212
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.206
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 2.200
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.195
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.158
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.134
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.049
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.033
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 1.998
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 1.996
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 1.994
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 1.984
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 1.978
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 1.974
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 1.945
The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone 1.923
Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients 1.876
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 1.867
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.856
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.855
The Italian multiple sclerosis register 1.845
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.828
The risk of bipolar disorders in multiple sclerosis 1.827
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.826
Totale 297.392
Categoria #
all - tutte 536.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 536.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.324 0 0 0 0 0 0 0 0 0 0 1.716 4.608
2020/2021105.907 3.083 4.062 4.857 24.794 19.140 13.273 9.905 7.691 3.352 6.296 5.866 3.588
2021/202219.556 2.607 1.488 880 1.633 1.641 1.192 889 965 1.828 1.971 2.385 2.077
2022/202325.276 2.399 3.587 3.377 2.012 1.978 2.629 1.021 2.241 1.494 1.561 1.817 1.160
2023/202425.498 1.717 1.379 914 1.899 2.630 3.971 2.736 2.234 1.266 2.153 2.465 2.134
2024/202565.957 22.181 21.114 7.671 4.106 2.654 2.740 3.703 381 685 651 71 0
Totale 437.391